As other fusion oncoproteins, such as RUNX1/ETO, behave similarly [10], translocation products may subsume the function of an otherwise compulsory combination of driver mutations found in normal karyotype AML [11]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.